Celsius Therapeutics Company
Celsius Therapeutics is a biotechnology company that develops precision medicines for cancer and autoimmune disease patients.
Technology:
Biotechnology, Emergency Medicine, Genetics, Health Care
Industry:
Early Drug Development
Headquarters:
Cambridge, Massachusetts, United States
Founded Date:
2018-01-01
Employees Number:
1-10
Funding Status:
Early Stage Venture
Investors Number:
11
Total Funding:
148000000
Estimated Revenue:
$1M to $10M
Last Funding Date:
2022-03-24
Last Funding Type:
Series B
Register and Claim Ownership